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ABSTRACT 
Background: 
Despite the well-known relationship between sleep disorders and general cardiovascular risk, 
relatively few studies have examined sleep quality and quality at pre-clinical levels in patients with 
cardiac arrhythmias (CA). Patients with CA have at a greatly elevated risk of stroke, sudden 
cardiac death, disability, and reduced quality of life. In this study, we therefore sought to elucidate 
the sleep-related predictors of arrhythmia by examining the relationship between objective 
(polysomnography assessed) and self-reported measures of sleep quality and quantity with CA. 
Methods: 
Baseline, comorbidity, electrocardiogram, and polysomnography data for all who participated in 
the Sleep Heart Health Study (age 44-90 y) was screened for this analysis. Participants with 
missing critical data were excluded from the final analysis. ECG data was utilized to find 
participants with cardiac arrhythmias. Exposure variables included blood oxygen saturation, sleep 
stages, and tertiles of sleep quality and quantity. Unadjusted and adjusted logistic regression was 
used to quantify the association between sleep and non-sleep related factors and arrhythmia.  
Results: 
Of the original SHHS sample, a total of 3,453 participants with complete variables of interest were 
included in the final analysis (mean age: 68.1± 10.6 Years, 54% male, 499 with arrhythmia 
(Rhythm Abnormalities and Conduction Abnormalities), and 2,954 with no pathology). At the 
bivariate level, underweight (OR: 2.86, 95% CI: 1.1 – 7.2, P<0.0001), sleep time < 6 hours (OR: 
2.58, 1.5-4.3, P<0.0001), % time in REM sleep (<17.6; OR: 1.53, 1.2-1.0, P<0.0001), sleep 
efficiency (<81; OR: 1.9, 1.5-2.3 ) and regular afternoon naps (OR:1.8, 1.3-2.4, P<0.0001) were 
 iii 
significantly associated with CA. However, in age- and sex-adjusted analyses, only % time in 
REM sleep and minimum oxygen saturation during REM (OR: 0.97, 0.96-0.98, P=0.006, and; OR: 
0.97, 0.96-0.98, P=0.001, respectively) remained associated with CA.  
Conclusion: 
Preliminary analyses suggest differences in the sleep stages and oxygen delivery as potential 
targets for future work in the prevention and early management of CA. Further study is necessary 
to understand the nature of these relationships using longitudinal data with adjustment for 
traditional CA markers.  
 
Keyword: Cardiac Arrhythmia, Atrial Fibrillation, Polysomnography data, Sleep Measures, 
Sleep Quality, Rhythm Abnormality, Conduction Abnormality, Sleep Efficiency, WASO, Sleep 
Quantity 
 
 
 
 
 
 
 
 
 iv 
 
ACKNOWLEDGMENTS 
 
“The more I learn, the more I realize how much I don't know.” 
         - Albert Einstein 
As I come to the end of this chapter of my life, I cannot ignore the tremendous impact that people 
around me had on my success. First and foremost, I would like to express the sincerest of gratitude 
to my supervisor, and mentor Dr. Chris Ardern. Your continuous support throughout my 
undergraduate and further graduate career allowed me to learn and excel in the field. I have learned 
from you, skills that will allow me to further grow as I embark in the next chapter of my life. Thank 
you for always being supporting and understanding, I could not have done this without your kind 
and continuous encouragement. I would like to also take this opportunity to thank Dr. Jennifer 
Kuk, who kindly provided me with very useful and constructive feedback throughout this journey. 
The comments I received from you after my presentation and throughout this journey allowed me 
to further reflect on my analysis and writing plan. Most importantly, I would like to thank you for 
providing me with the data needed to run the analysis and undertake the current project.  
I would also like to thank Dr. Yaariv Khaykin, another individual whose guidance have for most 
part shaped me into the person I am today and equipped me with the knowledge necessary to do 
this is study. Dr. Khaykin, I have said this before, and will always say until my last breath that you 
were the one who took me in, helped me grow, gave me wings, and allowed me to fly, you changed 
my life, and for that I am forever indebted to you. Thank you for being someone I could always 
count and rely on.   
Meysam Pirbaglou, my friend who was always there by my side, and helped me navigate the road 
from undergraduate studies to this day deserves the deepest of appreciations. Meysam, thank you 
for being there, I could not have done it if it wasn’t for your continuous optimism and kindness. I 
wish you all the best in your doctorate defense and all your future endeavours.  
Finally, I would like to thank my very kind and patient wife, parents, and brother. Zahra, you were 
always there for me and supported me when times got hard. You are my rock and I know that I 
can always rely on you, even in the worst of times. This success is as much yours as it is mine, and 
I wish you nothing but continued success and happiness in the days to come. To my parents, and 
brother who also cheered me on, even during times when I was too tired to carry on, thank you for 
always being there. 
 
I also would like to thank York University’s department of Kinesiology and Health Science for 
their support of my studies.  
 
 
 
 v 
 
 
TABLE OF CONTENTS 
 
ABSTRACT ............................................................................................................................ ii 
ACKNOWLEDGMENTS ...................................................................................................... iv 
TABLE OF CONTENTS ........................................................................................................ v 
AUTHOR CONTRIBUTION ................................................................................................ viii 
ABBREVIATIONS ................................................................................................................. ix 
Figure and Tables .................................................................................................................. x 
Figure 1: Consort Flow Diagram of Participant Selection for the study. ..................................................................... x 
Figure 2: Afternoon Nap habit of participants. * = P<0.05 ........................................................................................ xi 
Table 1: Demographics and Characteristics ............................................................................................................... xii 
Table 2: Comparing the difference in Sleep Quality variables and time spent in each Sleep stage between NSR and 
those with CA ............................................................................................................................................................. xiv 
Table 3: Comparing the difference in Oxygenation During different sleep stages between NSR and those with CA . xv 
Table 4: Sleep quality and percent time spent in different stages of sleep as predictor of Arrhythmia manifestation
 .................................................................................................................................................................................. xviii 
Table 5: Oxygenation During various stages of sleep as predictor of Arrhythmia manifestation ............................... xx 
Table 6: Napping as predictor of Arrhythmia manifestation ...................................................................................... xxi 
REVIEW OF THE LITERATURE ......................................................................................... 1 
Introduction ................................................................................................................................................................... 1 
Context for the Study of Sleep and Its Relationship to Health ....................................................................................... 2 
Importance of Sleep ....................................................................................................................................................... 3 
Physiology of Sleep ....................................................................................................................................................... 3 
Stages of Sleep ............................................................................................................................................................... 5 
Non-Rapid Eye Movement Sleep ................................................................................................................................... 5 
Rapid Eye Movement Sleep ........................................................................................................................................... 7 
 vi 
Sleep Study and Pathologies ......................................................................................................................................... 8 
Physiology and Pathologies of the Conduction system ............................................................................................... 10 
OBJECTIVES ...................................................................................................................... 12 
INTRODUCTION ................................................................................................................ 13 
METHODS .......................................................................................................................... 14 
Study Design ................................................................................................................................................................ 14 
Sleep Heart Health Study ............................................................................................................................................ 14 
Outcomes ..................................................................................................................................................................... 14 
Cardiac Arrhythmia ................................................................................................................................................ 15 
Rhythm Abnormalities ............................................................................................................................................. 15 
Conduction Abnormalities ...................................................................................................................................... 15 
Objective Sleep Variables (Polysomnography) ........................................................................................................... 15 
Sleep Stages and progression .................................................................................................................................. 16 
Quantity and Quality of Sleep Measures ................................................................................................................. 16 
Wake After Sleep Onset (WASO) ............................................................................................................................. 16 
Sleep Efficiency ....................................................................................................................................................... 16 
Sleep Latency .......................................................................................................................................................... 17 
Sleep to awake shift (SWS) ...................................................................................................................................... 17 
Arterial Oxygen Saturation During Various Stages of Sleep .................................................................................. 17 
Subjective Sleep Variable ............................................................................................................................................ 17 
Sample Selection ......................................................................................................................................................... 18 
Inclusion Criteria .................................................................................................................................................... 18 
Exclusion Criteria ................................................................................................................................................... 18 
Participant Screening and Outcome Assignment .................................................................................................... 18 
Statistical Analysis ...................................................................................................................................................... 18 
Ethics ........................................................................................................................................................................... 19 
RESULTS ............................................................................................................................ 20 
Study Population ......................................................................................................................................................... 20 
Sample Selection ..................................................................................................................................................... 20 
Demographic and Clinical Characteristics ............................................................................................................ 20 
 vii 
Sleep Quality Measures .......................................................................................................................................... 21 
Oxygenation at Various sleep stages ...................................................................................................................... 21 
Sleep Progression and Stages ................................................................................................................................. 22 
Napping Habits ....................................................................................................................................................... 22 
Sleep Related Predictors of Cardiac Arrhythmia manifestation ................................................................................. 22 
Sleep Quality Measures ............................................................................................................................................... 23 
Sleep Time ............................................................................................................................................................... 23 
WASO ...................................................................................................................................................................... 23 
Sleep Efficiency ....................................................................................................................................................... 23 
Oxygenation at Various sleep stages ........................................................................................................................... 24 
Minimum Arterial Blood Saturation ....................................................................................................................... 24 
Mean Arterial Blood Saturation .............................................................................................................................. 24 
Disturbances to Regular Blood Oxygenation .......................................................................................................... 24 
Sleep Stage Progression .............................................................................................................................................. 25 
Subjective Measures of sleep: Naps ............................................................................................................................ 25 
DISCUSSIONS .................................................................................................................... 25 
Main Findings ............................................................................................................................................................. 25 
Sleep Quantity and Deprivation .................................................................................................................................. 26 
Wake after sleep onset (WASO) and Sleep Efficiency ................................................................................................. 27 
Rapid Eye Movement Sleep and Oxygenation ............................................................................................................. 28 
Sleep Apnea and Arrhythmia ....................................................................................................................................... 29 
Afternoon Naps and Prevalence of Arrhythmia ........................................................................................................... 30 
Strengths and Limitations ............................................................................................................................................ 31 
CONCLUSION .................................................................................................................... 31 
References ............................................................................................................................ 32 
 
 
 
 
 
 viii 
 
 
 
 
AUTHOR CONTRIBUTION 
Publications: 
- Sleep and Cardiac Tachyarrhythmia: Results from the Cross-Sectional Sleep Heart Health 
Study – Canadian Cardiovascular Congress – Fall 2019 – Montreal, QC, Canada 
Author Contribution: 
- Study Concept and Design: Pouria Alipour and Chris I. Ardern 
- Acquisition of Data: Pouria Alipour, Jennifer Kuk and Chris I. Ardern 
- Analysis and Interpretation of Data: Pouria Alipour and Chris I. Ardern 
- Drafting of Manuscript: Pouria Alipour 
- Manuscript revision for important intellectual content: Pouria Alipour, Jennifer Kuk and 
Chris I. Ardern 
- Statistical Analysis: Pouria Alipour 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 ix 
 
 
 
 
ABBREVIATIONS 
CA  Cardiac Arrhythmia 
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Figure 2: Afternoon Nap habit of participants. * = P<0.05  
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 Total  
(n=3,453) 
NSR 
(n=2,954) 
Cardiac 
Arrhythmia 
(n=499) 
Rhythm 
Abnormalities 
(n=236) 
Conduction 
Abnormalities 
(n=263) 
% Male*†‡ 
 
54% 55.8% 56.3% 55.1% 57.4% 
Mean Age*†‡ 
 
68.1±10.6 67±10.5 74.4±9.2 74.6±9.3 74.1±9.1 
Race 
White 
Black 
Other 
 
87.8% 
6.1% 
6.1% 
 
87.5% 
5.8% 
6.7% 
 
89.6% 
8.2% 
2.2% 
 
90.3% 
7.2% 
2.5% 
 
89% 
9.1% 
1.9% 
Marital Status 
Married 
Divorced 
Widowed 
Never 
Married 
 
81% 
7.7% 
8.4% 
2.8% 
 
 
81% 
8.1% 
7.9% 
3% 
 
80.8% 
5.4% 
11.6% 
1.6% 
 
79.7% 
11.9% 
5.9% 
2.5% 
 
82.7% 
11.5% 
5% 
0.8% 
Hypertension*†‡ 
 
55.9% 53% 
 
72.9% 73.3% 72.6% 
History of 
Myocardial 
Infarction 
(MI)*†‡ 
5.3% 4.9% 12.2% 13.6% 11% 
History of 
Stroke 
3.1% 2.7% 5.6% 5.9% 5.3% 
Congestive 
Heart Failure 
(CHF)* 
1.6% 1.4% 2.2% 3.8% 0.8% 
History of 
Coronary Artery 
Bypass Graft 
3.2% 2.3% 8.4% 8.1% 8.8% 
Table 1: Demographics and Characteristics 
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Procedure 
(CABG)*†‡ 
History of 
Coronary Artery 
Disease (CAD)† 
2.8% 2.3% 5.2% 5.9% 4.6% 
History of 
Chronic 
Obstructive 
Pulmonary 
Disease (COPD)‡ 
1.8% 1.4% 2.6% 2.1% 3% 
BMI 
≤17.9 
18-24.9 
25-29.9 
30-34.9 
35-39.9 
≥40 
 
0.6% 
25.7% 
42.2% 
21.9% 
7.2% 
2.4% 
 
0.5% 
25.8% 
41.9% 
21.7% 
7.4% 
2.6% 
 
1.4% 
24.9% 
43.7% 
22.7% 
5.9% 
1.4% 
 
1.7% 
28.1% 
42.4% 
21.6% 
4.8% 
1.4% 
 
1.5% 
22.1% 
44.9% 
23.6% 
6.8% 
1.1% 
 xiv 
Table 2: Comparing the difference in Sleep Quality variables and time spent in each Sleep stage 
between NSR and those with CA (P<0.05=*). These patients were further subdivided and 
categorized to RA (P<0.05=†), and Conduction Abnormalities (P<0.05=‡), and compared to 
participants in the NSR group. 
 
 
 
 NSR (n=2,954) Cardiac 
Arrhythmia 
(n=499) 
Rhythm 
Abnormalities 
(n=236) 
Conduction 
Abnormalities 
(n=263) 
Sleep Time 
(Minutes)*†‡ 
603.4±99.20 581.3±107.7 575.4±106.9 586.6±108.3 
WASO 
(Minutes)*†‡ 
58.1±40.1 69.9±47.8 72.7±50.8 67.4±44.8 
Sleep 
Efficiency 
(%)*†‡ 
83.9±9.53 80.8±11.1 80.3±11.4 81.6±10.8 
Sleep Latency 
(Seconds) 
805.1±1162 864.2±1240 906.6±1355 825.0±1127 
Sleep to Awake 
Shift*†‡ 
27.9±13.1 30.4±16.6 31.2±18.1 29.6±15.1 
% Time in 
SA*†‡ 
2.7±6.1 4.8±8.8 4.3±8.3 5.5±9.4 
% Time in 
Hypopnea*‡ 
16.5±8.82 18.3±9.10 17.6±8.34 19.1±9.87 
% Time in 
NREM Stage 1 
5.2±3.7 6.1±4.5 5.9±4.6 6.2±4.5 
% Time in 
NREM Stage 2 
56.2±11.4 58.1±12 57.7±11.7 58.4±12.4 
% Time in 
NREM Stage 
3/4‡ 
18.2±11.4 16.9±12.3 17.9±12.1 15.8±12.5 
% Time in 
REM*†‡ 
20.4±6.03 18.8±6.11 18.3±6.00 19.4±6.12 
 xv 
 
 
 
Table 3: Comparing the difference in Oxygenation During different sleep stages between NSR 
and those with CA (P<0.05=*). These patients were further subdivided and categorized to RA 
(P<0.05=†), and Conduction Abnormalities (P<0.05=‡) and compared to participants in NSR 
group.   
 
 
 
 
 
 
 
  
  
 
 NSR 
(n=2,954) 
Cardiac 
Arrhythmia 
(n=499) 
Rhythm 
Abnormalities 
(n=236) 
Conduction 
Abnormalities 
(n=263) 
Average 
SaO2 REM 
(%)*‡ 
94.2±5.51 93.4±6.57 93.3±6.62 93.4±6.61 
Average 
SaO2 
NREM 
(%)* 
94.6±1.80 92.6±2.04 94.2±1.85 94.3±2.21 
Min SaO2 
REM (%)*‡ 
86.9±7.46 85.5±8.30 85.6±8.33 85.5±8.32 
Min SaO2 
NREM 
(%)*† 
87.5±5.03 86.1±6.27 86.3±5.48 85.9±6.88 
  Cardiac Arrhythmia (n=499) Rhythm Abnormalities (n=236) Conduction Abnormalities 
(n=263) 
Univariate 
Unadjusted 
Model 
OR (95%CI) 
Age and Sex 
Adjusted 
Model 
OR (95%CI) 
Univariate 
Unadjusted 
Model 
OR (95%CI) 
Age and Sex 
Adjusted 
Model 
OR (95%CI) 
Univariate 
Unadjusted 
Model 
OR (95%CI) 
Age and Sex 
Adjusted 
Model 
OR (95%CI) 
% Time in 
REM  
£17.5 
17.6-22.5 
³22.6 
 
 
1.53(1.2-1.9) 
1.36(1.1-1.7) 
1.0 (Referent) 
 
 
1.1(1.0-1.3) 
1.2 (0.92-1.8) 
1.0 (Referent) 
 
 
1.1(0.8-1.5) 
1.1(0.8-1.5) 
1.0 (Referent) 
 
 
0.84(0.56-1.2) 
0.94(0.67-1.3) 
1.0 (Referent) 
 
 
2.1(1.5-2.9) 
1.73(1.2-2.4) 
1.0 (Referent) 
 
 
1.7(1.2-2.4) 
1.5(1.1-2.2) 
1.0 (Referent) 
% Time Stage 
1 NREM 
£3.3 
3.4-5.9 
³6 
 
 
 
1.0 (Referent) 
1.1(0.8-1.4) 
1.5(1.2-1.8) 
 
 
1.0 (Referent) 
1.1(0.87-1.4) 
1.2(0.94-1.5) 
 
 
1.0 (Referent) 
1.1(0.8-1.6) 
1.5(1.1-2.1) 
 
 
1.0 (Referent) 
1.1(0.80-1.6) 
1.3(0.89-1.7) 
 
 
1.0 (Referent) 
1.1(0.7-1.5) 
1.4(1.1-1.9) 
 
 
1.0 (Referent) 
1.1(0.78-1.5) 
1.1(0.84-1.6) 
% Time Stage 
2 NREM 
£51.7 
51.8-61.6 
³61.7 
 
 
1.0 (Referent) 
0.9(0.7-1.2) 
1.45(1.2-1.8) 
 
 
 
 
1.0 (Referent) 
0.95(0.73-1.2) 
1.0(0.80-1.3) 
 
 
1.0 (Referent) 
1(0.7-1.4) 
1.6(1.2-2.2) 
 
 
1.0 (Referent) 
1.0(0.69-1.4) 
1.2(0.82-1.6) 
 
 
1.0 (Referent) 
0.9(0.7-1.3) 
1.31(1.1-1.7) 
 
 
1.0 (Referent) 
0.92(0.66-1.3) 
0.92(0.66-1.2) 
 xvii 
% Time Stage 
3/4 NREM 
£11.9 
12-22.1 
³22.2 
 
 
1.4(1.1-1.7) 
0.9(0.7-1.1) 
1.0 (Referent) 
 
 
0.96(0.75-1.2) 
0.82(0.63-1.0) 
1.0 (Referent) 
 
 
1.6(1.2-2.1) 
0.8(0.5-1.1) 
1.0 (Referent) 
 
 
1.2(0.83-1.6) 
0.80(0.56-1.2) 
1.0 (Referent) 
 
 
1.1(0.84-1.6) 
0.87(0.71-1.2) 
1.0 (Referent) 
 
 
0.82(0.58-1.1) 
0.86(0.62-1.2) 
1.0 (Referent) 
WASO 
(Minutes) 
£34.9 
35-64.9 
     ³65 
 
 
1.0 (Referent) 
1.3(1-1.7) 
1.8(1.5-2.3) 
 
 
1.0 (Referent) 
1.0(0.79-1.3)1. 
1.1(0.85-1.4) 
 
 
1.0 (Referent) 
1.2(0.8-1.7) 
2.2(1.6-3.1) 
 
1.0 (Referent) 
0.90(0.61-1.3) 
1.4(1.0-1.9) 
 
1.0 (Referent) 
1.5(1.1-2.1) 
1.5(1.1-2.2) 
 
1.0 (Referent) 
1.1(0.81-1.5) 
0.88(0.63-1.2) 
Sleep 
Efficiency 
(%) 
£80.9 
81-89.9 
     ³90 
 
1.9(1.5-2.3) 
1.2(0.9-1.5) 
1.0 (Referent) 
 
1.1(0.87-1.4) 
0.92(0.71-1.2) 
1.0 (Referent) 
 
2.2(1.6-3.1) 
1.2(0.8-1.7), .35 
1.0 (Referent) 
 
1.5(1.1-2) 
0.92(0.63-1.3) 
1.0 (Referent) 
 
1.6(1.2-2.2) 
1.2(0.9-1.7) 
1.0 (Referent) 
 
1.0(0.72-1.4) 
0.97(0.70-1.4) 
1.0 (Referent) 
Sleep Latency 
(Seconds) 
0 
1-14.5 
    ³14.6 
 
 
1.0 (Referent) 
1.0 (0.77-1.3) 
1.2(0.91-1.5) 
 
 
 
 
1.0 (Referent) 
1.1 (0.83-1.7) 
1.2(0.94-1.5) 
 
 
1.0 (Referent) 
0.91(0.73-1.3) 
1.2(0.81-1.5) 
 
 
1.0 (Referent) 
0.98 (0.69-1.4) 
1.1(0.82-1.5) 
 
 
1.0 (Referent) 
1.1(0.79-1.5) 
1.2(0.93-1.6) 
 
 
1.0 (Referent) 
1.2 (0.83-1.6) 
1.2(0.92-1.7) 
 xviii 
Table 4: Sleep quality and percent time spent in different stages of sleep as predictor of Arrhythmia manifestation.  All continuous 
variables were categorized into tertiles for analysis.    
 
 
Sleep to 
Awake Shift 
£20.9 
21-30.9 
     ³31 
 
 
1.0 (Referent) 
1.1(0.84-1.3) 
1.3(1.0-1.6) 
 
 
1.0 (Referent) 
0.91(0.71-1.1) 
0.98(0.77-1.3) 
 
 
1.0 (Referent) 
0.91(0.58-1.3) 
1.3(0.88-1.6) 
 
 
1.0 (Referent) 
0.85(0.60-1.2) 
1.1(0.74-1.5) 
 
 
1.0 (Referent) 
1.1(0.82-1.5) 
1.3(0.91-1.8) 
 
 
1.0 (Referent) 
0.96(0.70-1.3) 
0.95(0.67-1.3) 
 xix 
 Cardiac Arrhythmia (n=499) Rhythm Abnormalities (n=236) Conduction Abnormalities (n=263) 
Univariate 
Unadjusted 
Model 
OR (95%CI) 
Age and Sex 
Adjusted Model 
OR (95%CI) 
Univariate 
Unadjusted Model 
OR (95%CI) 
Age and Sex 
Adjusted Model 
OR (95%CI) 
Univariate 
Unadjusted Model 
OR (95%CI) 
Age and Sex 
Adjusted Model 
OR (95%CI) 
Mean SaO2 
REM (%) 
£93.8 
93.9-95.6 
³95.7 
 
 
2.1(1.7-2.7) 
1.5(1.1-1.9) 
1.0 (Referent) 
 
 
1.3(1-1.7) 
1.1(0.81-1.4) 
1.0 (Referent) 
 
 
2.3(1.6-3.1) 
1.1(0.8-1.6) 
1.0 (Referent) 
 
 
1.38(1.0-1.9) 
1.2(0.95-1.9) 
1.0 (Referent) 
 
 
2(1.4-2.8) 
1.9(1.3-2.6) 
1.0 (Referent) 
 
 
1.3(0.93-1.8) 
1.2(0.93-1.7) 
1.0 (Referent) 
Mean SaO2 
NREM (%) 
£93.9 
94-95.4 
³95.5 
 
 
1.6(1.3-2) 
1.1(0.8-1.4) 
1.0 (Referent) 
 
 
1.0(0.81-1.3) 
0.83(0.64-1.1) 
1.0 (Referent) 
 
 
1.7(1.2-2.3) 
1.5(1-2.1) 
1.0 (Referent) 
 
 
0.65(0.45-0.94) 
1.1(0.80-1.6) 
1.0 (Referent) 
 
 
1.5(1-2) 
1.4(0.9-1.6) 
1.0 (Referent) 
 
 
0.96(0.68-1.3) 
1.0(0.72-1.4) 
1.0 (Referent) 
Min SaO2 REM 
(%) 
£85.9 
86-89.9 
³90 
 
 
1.7(1.3-2.1) 
1.5(1.2-1.9) 
1.0 (Referent) 
 
 
 
1.4(1.1-1.7) 
1.2(0.95-1.5) 
1.0 (Referent) 
 
 
1.7(1.2-2.4) 
1.5(1.2-2.1) 
1.0 (Referent) 
 
 
1.3(0.96-1.8) 
1.2(-.84-1.7) 
1.0 (Referent) 
 
 
1.7(1.2-2.3) 
1.6(1.1-2.1) 
1.0 (Referent) 
 
 
1.3(0.93-1.8) 
1.2(0.90-1.7) 
1.0 (Referent) 
 xx 
 
 
 
 
 
 
 
Min SaO2 
NREM (%) 
£86.9 
87-89.9 
³90 
 
 
1.8(1.4-2.3) 
1.4(1.1-1.8) 
1.0 (Referent) 
 
 
1.3(0.94-1.6) 
1.1(0.86-1.4) 
1.0 (Referent) 
 
 
1.8(1.3-2.5) 
1.5(0.9-2.1) 
1.0 (Referent) 
 
 
1.3(0.93-1.8) 
1.2(0.83-1.7) 
1.0 (Referent) 
 
 
1.8(1.3-2.5) 
1.4(1-1.9) 
1.0 (Referent) 
 
 
1.3(0.92-1.7) 
1.1(0.78-1.5) 
1.0 (Referent) 
% Time in 
Apnea 
£0.2 
0.3-1.49 
     ³1.5 
 
 
1.0 (Referent) 
1.2(0.91-1.5) 
2.1(1.6-2.6) 
 
 
1.0 (Referent) 
1.0(0.80-1.6) 
1.2(0.96-1.6) 
 
 
1.0 (Referent) 
1.0(0.66-1.5) 
2.1(1.5-2.9) 
 
 
1.0 (Referent) 
0.90(0.62-1.3) 
1.3(0.90-1.8) 
 
 
1.0 (Referent) 
1.4(0.9-1.9) 
2.0(1.4-2.7) 
 
 
1.0 (Referent) 
1.2(0.83-1.6) 
1.2(0.84-1.6) 
%Time in 
Hypopnea 
£11.8 
11.9-19.3 
     ³19.4 
 
 
1.0 (Referent) 
1.2(0.9-1.5) 
1.5(1.2-1.9) 
 
 
1.0 (Referent) 
0.98(0.76-1.2) 
1.00(81-1.4) 
 
 
1.0 (Referent) 
1.3(0.9-1.8) 
1.7(1.2-2.4) 
 
 
1.0 (Referent) 
1.1(0.76-1.6) 
1.2(0.84-1.7) 
 
 
1.0 (Referent) 
1.1(0.8-1.5) 
1.4(1.1-1.9) 
 
 
1.0 (Referent) 
0.89(0.64-1.2) 
0.94(0.67-1.3) 
Table 5: Oxygenation During various stages of sleep as predictor of Arrhythmia manifestation. All continuous variables were categorized into 
tertiles for analysis.    
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Table 6: Napping as predictor of Arrhythmia manifestation. All continues variables  
 
 Cardiac Arrhythmia (n=499) Rhythm Abnormalities (n=236) Conduction Abnormalities (n=263) 
Univariate 
Unadjusted 
Model 
OR (95%CI)  
Age and Sex 
Adjusted Model 
OR (95%CI) 
Univariate 
Unadjusted 
Model 
OR (95%CI) 
Age and Sex 
Adjusted Model 
OR (95%CI) 
Univariate 
Unadjusted 
Model 
OR (95%CI) 
Age and Sex 
Adjusted Model 
OR (95%CI) 
Regular 
Afternoon Naps 
Never 
Sometimes 
Often 
Everyday 
 
 
1.0 (Referent) 
1(0.81-1.8) 
1.2(0.76-1.4) 
1.7(1.3-2.4) 
 
 
1.0 (Referent) 
1.3(0.98-1.7) 
1.3(0.92-2.0) 
1.6(1.2-2.2) 
 
 
1.0 (Referent) 
1.1(0.72-1.6) 
1.1(0.60-1.9) 
1.7(1.1-2.6) 
 
 
1.0 (Referent) 
1.4(0.95-2.0) 
1.2(0.70-2.1) 
1.5(1.0-2.4) 
 
 
1.0 (Referent) 
1.0(0.71-1.5) 
1.3(0.79-2.2) 
1.8(1.3-2.8) 
 
 
1.0 (Referent) 
1.3(0.86-1.8) 
1.5(0.90-2.4) 
1.7(1.1-2.6) 
# of Naps Per 
week 
None 
1 or more 
 
1.0 (Referent) 
1.9(1.5-2.3) 
 
1.0 (Referent) 
1.25(1.0-1.6) 
 
1.0 (Referent) 
1.7(1.3-2.4) 
 
1.0 (Referent) 
1.2(0.87-1.6) 
 
1.0 (Referent) 
1.9(1.4-2.6) 
 
1.0 (Referent) 
1.3(0.96-1.7) 
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REVIEW OF THE LITERATURE 
Introduction 
Cardiovascular Disease (CVD), which includes coronary artery disease, heart failure, and 
arrhythmias, is collectively one of the leading causes of morbidity and mortality worldwide. 
Although Cardiac Arrhythmia (CA) receives less attention that most other sub-types of CVD, the 
antecedents and future health complications of individuals with CA are becoming better known. 
Defined as any abnormality of the conduction system of the heart, CA is a condition which results 
in deviation from the normal sinus rhythm (NSR). Such pathologies could either affect the 
initiation, and propagation of the electrical current or the normal conduction pathway of the heart. 
Patients suffering from cardiac arrhythmias typically are more likely to have further complications 
such as stroke, heart failure, significant reduction in quality of life, and disability. The exact 
etiology of cardiac arrhythmias is not known; however, it is hypothesized that factors such as age, 
excess alcohol, tobacco, caffeine, and recreational drug consumption, overexertion, and genetics 
play a major role in its manifestation. A less explored, but emerging area of research relates to the 
risk of CA associated with poor sleep hygiene and consequent sleep deprivation and low sleep 
quality. Although there is clear evidence that obstructive sleep apnea can increase the risk of 
arrhythmia manifestation, such studies have failed to further investigate the relationship between 
variations in pre-clinical sleep and CA, which must be understood in order to enact primary 
prevention efforts in susceptible populations. In this study, we therefore sought to investigate the 
relationship between quality, quantity, and oxygenation during sleep using polysomnography data 
to cardiac arrhythmias.    
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Context for the Study of Sleep and Its Relationship to Health  
Every human being sleeps an average of 25 to 30 years over its life span (Baumann, 
Strauch, Lehmann, Borbély, & Brandeis, 2003; Edwards et al., 2010; Ford & Cooper-Patrick, 
2001; Harding & Feldman, 2008; Jike, Itani, Watanabe, Buysse, & Kaneita, 2018; Night, Antidote, 
& Epidemic, 2017). Indeed, sleep is one of the most important daily routines, as it is the period of 
time in which one’s body rests and resets for another active day(Edwards et al., 2010). An adequate 
amount of sleep is therefore critical to survival and optimal everyday function(Baumann et al., 
2003). To date, a number of studies have demonstrated the adverse outcome of insomnia(Ford & 
Cooper-Patrick, 2001; Harding & Feldman, 2008; Jike et al., 2018). Recently, the study of 
somnology – which describes the scientific and clinical study of sleep, quality, stages, and 
disorders – have also shown a marked decline in population sleep quality and quantity(Edwards et 
al., 2010; Shochat, 2012). This in part is a direct result of advancement and developments of 
information technology, the ubiquity of social media, and other popular online 
platforms(Cleveland, 2011). The exact mechanism of sleep initiation will be discussed in the 
following section, but in summary, the increased exposure to light emitting diodes, and unfiltered 
blue light has resulted in reduction of active melatonin in the brain which is responsible for proper 
sleep initiation(Cleveland, 2011). As such, sleep hygiene is one of the most important 
considerations in cardiovascular, neurological, and psychological health(Baumann et al., 2003; 
Bryant & Gómez, 2015; Edwards et al., 2010; Ford & Cooper-Patrick, 2001; Harding & Feldman, 
2008; Jike et al., 2018; Night et al., 2017; Reite, Jackson, Cahoon, & Weil, 1975; R Stickgold, 
Hobson, Fosse, & Fosse, 2001). 
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Importance of Sleep  
Sleep is important for efficient learning, memory formation, concentration and reaction-
response situations(R Stickgold et al., 2001). The neural network of the brain is consistently 
remapping, and it is during sleep, that the majority of these reformations occur(Smith, 1985). Such 
networks and pathways are the roots of memory retention and learning. In particular, it is the Rapid 
Eye Movement stage of sleep that events stored in the short-term memory are often transferred 
and retained in the long-term memory(Smith, 1985, 1996; Smith & Rose, 1996) through a 
consolidation of procedural memory, however, the this does not hold true for  declarative memory 
consolidation(Smith, 1985). Therefore, it is crucial for one to have adequate amount of high-
quality sleep to learn and retain new memories. Sleep is also very crucial for maintaining a healthy 
cardiometabolic profile (Hoevenaar-Blom, Spijkerman, Kromhout, Van Den Berg, & Verschuren, 
2011). During the period of sleep the cardiovascular system slows down allowing the heart muscles 
to rest and relax(Wolk, Gami, Garciatouchard, & Somers, 2005). Similarly, vasodilation 
(relaxation of blood vessels) during sleep allows for better blood delivery and subsequent 
oxygenation to all parts of the body(Wolk et al., 2005). Adequate sleep is therefore important for 
one’s overall health and survival, as reductions in the quality and quantity of sleep have been 
implicated in an increased risk of hypertension, obesity, diabetes, and coronary artery 
disease(Jackson, Redline, & Emmons, 2015).  
Physiology of Sleep 
Sleep is a highly controlled process that is defined by a set schedule of sleep and awake 
cycles (Roehrs, 2000) that are referred to as the circadian rhythm - a process which is  dictated by 
the availability of, and lack of light (Depner, Stothard, & Wright, 2014). Controlled by the 
hypothalamus, a group of cells known as suprachiasmatic nucleus (SCN)(Carley & Farabi, 2016) 
are responsible for setting the biological clock (i.e. circadian rhythm), based on availability of 
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light. The process of sleep regulation has been studied extensively and thus far the two-process 
model has served as a major framework in understanding regulation of sleep-wake cycles(Carley 
& Farabi, 2016). Within this model, the S Phase refers to homeostatic process, which includes the 
signals received by the SCN from the body to regulate hemostasis and initiate sleep(Ephron & 
Carrington, 1966). On the other hand, the C process refers to circadian rhythm signalling(Borbély, 
Daan, Wirz-Justice, & Deboer, 2016; Ephron & Carrington, 1966). This process refers to the light 
and dark cycles, and its effects on sleep regulation. It is therefore the combination of the C and S 
phase signals that results in proper sleep regulation and initiation. While the exact mechanism of 
sleep is complex, in lower light conditions, the SCN sends signal to the pineal gland, which in 
turns releases a melatonin(Lewy, Ahmed, Jackson, & Sack, 1992). This hormone is responsible 
for initiation of sleep and is photosensitive, which means it will be destroyed if exposed to 
light(Akerstedt & Nilsson, 2003; Depner et al., 2014; Edwards et al., 2010; Irwin, Olmstead, & 
Carroll, 2016; Lewy et al., 1992; Luyster, Strollo, Zee, & Walsh, 2012; Rangaraj & Knutson, 2016; 
Roehrs, 2000). At the same time, the brain stem communicates with the hypothalamus, causing 
the sleep promoting cells to secrete GABA, a neurotransmitter which is responsible for reducing 
the state of arousal to help with sleep initiation(Pace-Schott & Hobson, 2002). The signals for 
sleep initiation are received from both the S process and C process. As a result, the S process 
signals when the body is in a state known as sleep debt(VAN DONGEN, ROGERS, & DINGES, 
2003), a state wherein an individual is sleep deprived and physiologically needs sleep to be able 
to function. 
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Stages of Sleep 
Number of different physiological changes are observed during sleep. Such changes have 
been extensively studied and are broadly defined as major sleep stages: i) the Rapid Eye Movement 
(REM), and; ii) Non-Rapid Eye Movement (NREM) stage. The NREM stage is further subdivided 
to four additional stages, each of which corresponds to a specific state of brain and cardiovascular 
activity(Loomis, Harvey, & Hobart, 1937). These substages are characterized by the depth of 
sleep, with NREM stage 4 being the deepest sleep. The REM-NREM stages are cyclical and occur 
in a particular order(Loomis et al., 1937; ROSS, JOHNSON, & WALTER, 1966). At the sleep 
onset, individuals typically exhibit characteristics for NREM 1, and gradually progress to stages 
2, 3, 4, before finally entering REM. Any disruption to the length, or percentage of each stage 
contribution may contribute to the development of a sleep disorder(Carskadon & Dement, 2017; 
Horner, 2017; McGinty & Szymusiak, 2017; Peever & Shiromani, 2017). A healthy individual 
spends on average 75%-80% of overall sleep in NREM stages while the other 20%-25% is spent 
in REM. Every NREM-REM cycle is typically 90-120 minutes in length, although this duration 
increases as the number of cycles increase throughout the night(McGinty & Szymusiak, 2017).  
Non-Rapid Eye Movement Sleep 
Within NREM sleep, stage 1 is typically described as the lightest sleep(Carskadon & 
Dement, 2017) and is known as a transitional stage from the state of wakefulness to sleep. Indeed, 
electroencephalograms during this stage of sleep reveal alpha waves that are similar to those 
observed in the wakefulness relaxation state, meaning that environmental disturbances can easily 
cause disruption to this stage of sleep(Carskadon & Dement, 2017). It is at this stage that the 
muscles relax, and respiration and heart rate begin to slow; nonetheless, individuals in this stage 
may experience the phenomenon of “hypnic jerk”, which is defined as sudden spasm of large 
muscles, sometimes experiencing the sensation of rapid fall(Carskadon & Dement, 2017). This is 
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one of the shortest stages of sleep, lasting up to 7 minutes, or 2%-5% of overall sleep 
time(Carskadon & Dement, 2017). On the other hand, the second stage of NREM sleep is typically 
the longest, contributing to 45%-55% of overall sleep time. This second stage of sleep is 
characterized by a manifestation of K- complexes and sleep spindles in the EEG tracing(Carskadon 
& Dement, 2017; Gais, Mölle, Helms, & Born, 2002). These forms are thought to play a major 
role in memory reconciliation and motor skill learning(Gais et al., 2002). K-complex are 
characterized by a single large spike in the EEG recordings, while sleep spindles are smaller in 
amplitude but higher in frequency(Forget, Morin, & Bastien, 2011). Previous studies have shown 
that brain spindles represent the transfer of information from hippocampus to neocortex which 
contributes to memory reconciliation; as a result, they been interpreted as a physiological index of 
intelligence(Anderer et al., 2001; Carskadon & Dement, 2017; Gais et al., 2002; Loomis et al., 
1937; McGinty & Szymusiak, 2017; ROSS et al., 1966), and a marker for schizophrenia (ROSS 
et al., 1966), restless leg syndrome, narcolepsy, and obstructive sleep apnea(Carskadon & Dement, 
2017; Lavigne & Montplaisir, 1994). The spindles and complexes in the stage 2 of NREM sleep 
also act as guardian, and protectors of sleep(McGinty & Szymusiak, 2017) as they allow the 
individual to be less reactive to external stimuli and maintain the sleep state(Forget et al., 2011). 
At this stage of sleep the core body temperature begins to decrease and further bradycardic 
response is observed(Carskadon & Dement, 2017). Finally, the third and fourth stages of NREM 
sleep are typically categorized together as they present very similar EEG tracings. Collectively, 
stage 3/4 sleep is considered the deepest sleep stage and as such slow wave sleep patterns as well 
as delta waveforms can be observed in the EEG tracing(Carskadon & Dement, 2017).  
 
 7 
Rapid Eye Movement Sleep 
One of the most studied stages of sleep is the rapid eye movement (REM) sleep. As the 
name suggests there is an increased frequency of the ocular muscles contraction resulting in rapid 
eye movement. This is the last stage of sleep in a sleep cycle and is typically characterized by large 
deviation from regular homeostasis state. Notably, EEG recording during REM sleep exhibit 
similar characteristics as the awake state, exhibiting desynchronized brain wave activity and theta 
waves also known as “sawtooth” pattern. This stage is also known as the stage of autonomic 
instability, due to increased fluctuations between sympathetic and parasympathetic nervous 
signals(Lanfranchi, Pépin, & Somers, 2017).  
Beyond the patterns described above, REM sleep is most well-known for muscle atonia 
(i.e. muscle paralysis), as this is the stage when most dreams occur, and this muscle paralysis will 
prevent against any potential acting out of one’s dreams(Solms, 2000; Robert Stickgold & 
Wamsley, 2017). Dreaming is defined as auditory, visual, and in some cases tactile hallucinations, 
in addition to increased heart rate, eye movement and emotional response(Nir & Tononi, 2010; 
Solms, 2000; Robert Stickgold, 2017; Robert Stickgold & Wamsley, 2017). These responses are 
similar to those seen during alert wakefulness state(Robert Stickgold & Wamsley, 2017). Auditory, 
visual and tactile experiences as a result of dreaming is typically stored in the short-term memory 
and are forgotten prior to or short after awakening(Nir & Tononi, 2010). Despite the ease by which 
a person can be awoken during REM sleep, maintenance of the awake state can be very difficult 
and short lived(Nir & Tononi, 2010). Of note, a number of studies have shown adverse 
cardiovascular outcomes as a result of disturbances to this stage of sleep(Nisha Aurora, 
Crainiceanu, Gottlieb, Kim, & Punjabi, 2018). Increased heart rate variability and unorganized 
breathing patterns are some of the mechanisms that allow adequate oxygenation and 
cardiovascular health at this stage (Nisha Aurora et al., 2018). As such, reduction in this stage of 
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sleep is correlated with higher risk of atherosclerosis, hypertension, hyperlipidemia, obesity, and 
other cardiometabolic disorders(Brown, Basheer, McKenna, Strecker, & McCarley, 2012; Irwin 
et al., 2016; Solms, 2000). By the same token, obstructive sleep apnea has the most pronounced 
adverse effect on this stage of sleep(Irwin et al., 2016). Epidemiological studies have shown that 
lack of proper oxygenation during this stage of sleep is also correlated with a higher incidence of 
cardiovascular diseases(Marin-Oto, Vicente, & Marin, 2019). Similar trends were not observed 
for NREM stages(Irwin et al., 2016). Fluctuations in blood pressure and heart rate are typically 
influenced by the autonomic nervous system during REM; therefore, there is an increased risk of 
myocardial infarction in the morning due to higher than normal blood pressure and heart 
rate(Pierdomenico et al., 2015). In summary, proper oxygenation and length of REM sleep is 
crucial for cardiometabolic health. 
Sleep Study and Pathologies 
To investigate qualitative and quantitative properties of sleep, individuals at higher risk of 
sleep disorders undergo an investigation known as polysomnography(Douglas, Thomas, & Jan, 
1992; Kushida et al., 2005, 2006), the study of physiological, neural, and cardiovascular changes 
during different stages of sleep(Kushida et al., 2006). This technique allows healthcare 
professionals to properly monitor and diagnose sleep disorders. This test is typically administered 
in a clinic overnight with the patient sleeping while attached to an electrocardiogram, 
electroencephalogram, electro-oculography, electromyography, blood pressure machine, pulse 
oximeter, and finally a microphone(Douglas et al., 1992). Throughout the night, the machines 
measure all physiological changes as well as noises made by the patient during sleep, such as 
snoring, as well as any talking(Kushida et al., 2005). Collectively, polysomnographic techniques 
allows for proper diagnosis of number of disorders (e.g. central sleep apnea, narcolepsy, restless 
 9 
leg syndrome, night terrors, insomnia, and nightmare disorder)(Coleman et al., 1982) though 
inspection of a hypnogram of the physiological changes at each stage of sleep(Douglas et al., 
1992).  
Obstructed sleep apnea (OSA) is one of the most important risk factors for number of 
cardiovascular diseases(Koo, Patel, Strohl, & Hoffstein, 2008b; Marin-Oto et al., 2019). 
Characterized by a reduction, or in some severe cases, a complete cessation of oxygen delivery 
during the various stages of sleep, individuals with suspected OSA will undergo polysomnography 
to determine the presence or absence of the disease(Kushida et al., 2006). Among the many 
complications of OSA, it is usually linked to early onset of coronary artery disease, hypertension, 
heart failure, and arrhythmias(Nisha Aurora et al., 2018) as a result of poor oxygen delivery during 
sleep and resulting hypoxia in major organs (Nisha Aurora et al., 2018). The effects of sleep apnea 
on the development and progression of arrhythmias has been well-studied and will be discussed in 
the following sections. Lastly, patients suffering from OSA have lower blood oxygen saturation 
throughout the night, which in some cases forces a person to wake up in order to catch their 
breath(Guilleminault, Tilkian, & Dement, 1976). This disturbance in sleep results in disruption of 
proper sleep stage progression, resulting in less restful sleep. Lifestyle modifications such as 
weight loss, exercise, smoking cessation, and reduction in alcohol consumption, as well as use of 
a Continuous Positive Airway Pressure (CPAP) ventilator, are some the treatments for 
OSA(Guilleminault et al., 1976).  In a randomized controlled trial investigating over 2,700 
participants, those with moderate to severe OSA who were randomized to usual care and CPAP 
therapy had higher quality of life improvement compared to those with just usual care, with no 
difference in recurrent cardiovascular events(McEvoy et al., 2016). Therefore, the effect of such 
therapy is still a subject of great debate (Marin-Oto et al., 2019; McEvoy et al., 2016; Nsair, Hupin, 
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Chomette, Barthélémy, & Roche, 2019; Randerath, Bonsignore, & Herkenrath, 2019). Moreover, 
most studies to date have investigated the simple correlation between blood oxygenation state and 
risk of cardiovascular events, with relatively little work on the relationship between sleep quality 
and stage progression and CVD.  
 
Physiology and Pathologies of the Conduction system 
Collectively, CVD represents one of the major causes of morbidity and mortality in older 
population internationally(Verrier & Josephson, 2009). Such disorders can range from coronary 
artery disease, which can ultimately result in myocardial infarction, to rhythm and functional 
abnormalities of the cardiac system(Verrier & Josephson, 2009). Cardiac Arrhythmia is defined 
as any disturbance to the normal rhythm and conduction pathway of the cardiac system(Kenny, 
2014). In short, an electrical impulse is generated at the pacemaker cells of the Sinoatrial (SA) 
node in the right atrium of the heart. These electrical currents are propagated throughout the 
atrium resulting in atrial contraction and emptying of blood from atrium to the ventricles. The 
electrical current then travels to the atrioventricular junction, where it is briefly slowed to allow 
atrium to empty. Once the electrical current passes through the AV node, it travels down the 
bundle of his, ultimately branching into the right and left bundle branches and purkinje 
fibres(Kenny, 2014). The electrical current travelling down the bundle branches results in the 
contraction of the right and left atrium, causing blood to travel to the pulmonary and systemic 
circulations, respectively(Kenny, 2014).  
Normal Sinus Rhythm (NSR) refers to the regular initiation, and propagation of electrical 
rhythms of the heart. Any deviation from the regular process of the conduction system results in 
pathologies known as cardiac arrhythmia (CA). Generally, arrhythmias are described as either 
 11 
rhythm (i.e. improper initiation and depolarization of the cardiomyocytes in either atrium, 
ventricle, or both) or conduction abnormalities (i.e. improper propagation of electrical signals 
throughout the heart). Rhythm abnormalities can further be classified as those of the upper 
chambers - known as atrial tachyarrhythmia, or those of the bottom chambers of the heart - 
ventricular tachycardias.(Ottoboni, Lee, & Zei, 2011) One further type of arrhythmia, known as 
supraventricular tachycardia, refers to an inappropriate circuit re-entry resulting in fast and 
unorganized heartbeat originating above the ventricular tissues(Buescher & Asirvatham, 2011; 
Ottoboni et al., 2011). To date, a number of studies have investigated the origin, cellular 
pathology, and etiology of these diseases, yet the exact cause of arrhythmia manifestation 
remains unknown(Kenny, 2014; Ottoboni et al., 2011; Tracy et al., 2013).  
Some of the most common rhythm abnormalities include atrial fibrillation, ventricular 
tachycardia, atrioventricular nodal re-entry, and atrial flutter(Beheiry, Al-Ahmed, & Natale, 
2011; Buescher & Asirvatham, 2011; Kenny, 2014). By the same token, major types of 
conduction abnormalities are left and right bundle branch block, first, second, or third 
atriovencular block, as well as fascicular block(Guettler et al., 2019; Kenny, 2014). These 
pathologies prevent the proper propagation of electrical current, thereby resulting in cardiac 
arrhythmias(Guettler et al., 2019). The arrhythmias of the upper chambers are rarely life 
threatening, but commonly result in diminished quality of life(Beheiry et al., 2011; Buescher & 
Asirvatham, 2011; Cook & Hsia, 2011; Guettler et al., 2019; Ottoboni et al., 2011). By contrast, 
ventricular tachycardias such as ventricular tachycardia and ventricular fibrillation are life 
threatening if not adequately treated(Cook & Hsia, 2011). Because treatments are not completely 
effective and recurrences are frequent, primary prevention efforts are sorely needed.  
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OBJECTIVES 
The objectives of this thesis are therefore two-fold: 
1. To evaluate the differences in objective and subjective sleep measures amongst those 
with and without different types of cardiac arrhythmias. 
2. To determine the predictors of Cardiac Arrhythmias including rhythm and conduction 
abnormalities. 
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INTRODUCTION 
 
Almost one third of every human’s life is spent sleeping(Luyster et al., 2012). The 
importance of sleep as a process crucial to memory reconciliation, neurological health, and proper 
cardiovascular functioning (Edwards et al., 2010; Smith, 1996; R Stickgold et al., 2001) is now 
well known.(Depner et al., 2014; Ford & Cooper-Patrick, 2001; Knutson et al., 2009; Luyster et 
al., 2012) Sleep is a protected period for the cardiovascular system to rest and prepare for the 
functioning of the coming day,(Verrier & Josephson, 2009) but it is also a very dangerous time for 
the cardiovascular system as 20% of myocardial infarctions and 15% of overall sudden cardiac 
deaths occur during sleep(Pavwoski & Shelgikar, 2017). Obstructive sleep apnea (OSA) is 
purported to be the main culprit for such occurrences(Porto, Sakamoto, & Salles, 2017), as a lack 
of proper oxygenation due to OSA results in reduction of blood oxygen saturation. The resulting 
transient ischemia can result in myocardial infarction and disruption of normal sinus rhythm of the 
heart(Guilleminault et al., 1976; Porto et al., 2017; Verrier & Josephson, 2009). If left untreated, 
OSA can result in cardiac remodelling which will further complicate the rhythm of the heart and 
cause manifestation of novel arrhythmias(Dimitri et al., 2012; Linz et al., 2018). Therefore, proper 
oxygenation during sleep is of utmost importance. Although a number of studies have investigated 
the relationship between OSA and cardiac arrhythmias (Verrier & Josephson, 2009),  the impact 
of sleep on arrhythmogenesis is not well known. In this study, we therefore sought to investigate 
the relationship between various measures of objectively measured sleep and cardiac 
tachyarrhythmias in order to better understand opportunities for risk reduction.  
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METHODS 
Study Design 
Data for this analysis was derived from the Sleep Heart Health Study (SHHS) which was 
obtained through a limited access request to the U.S. National Heart, Lung, and Blood Institute 
(NHLBI). The SHHS is a harmonized dataset of four cohort studies with self-perceived and 
directly assessed measures of sleep quality and quantity on which to examine patterns of sleep and 
arrhythmia. Physical, physiological, and sleep data for all consented participants were collected 
and utilized in the analysis of this study. Objective sleep measure variables were obtained via a 
polysomnography study of participants. During this time heart rate, continuous ECG, breathing 
rate, and blood pressure data were also collected.  
Sleep Heart Health Study 
Sponsored by the National Heart, Lung, and Blood Institute (NHLBI) in the United States 
of America (USA), the Sleep Heart Health Study (SHHS), was one the largest studies investigating 
the effects of sleep breathing on cardiovascular health. This was a longitudinal study which was 
divided into two phases. Phase 1 (SHHS1) and phase 2 (SHHS2) of this study enrolled and 
collected general, cardiovascular, and family history, along with anthropometric, 
electrophysiologic, and polysomnographic data from 6,441 participants older than 40 years of age 
in in 1995-1998 and 2001-2003 respectively. All participants were subsequently followed up until 
2010, and any manifestation of cardiovascular disease outcome was recorded.  
Outcomes 
On the basis of previous literature(B.J. et al., 2016), participants were divided into 
subgroups without any history of arrhythmia (NSR) or those with evidence of arrhythmia (CA). 
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Participants within the CA group were further divided into those with Rhythm Abnormalities (RA) 
and Conduction Abnormalities (CAb) based on their ECG findings. Participants were assigned to 
RA and CAb subgroups depending on whether the ECGs trace found abnormal rhythm or 
conduction morphologies. The primary outcome of interest was any CA, while secondary 
outcomes include subgroups of CA during second visit of Sleep Heart Health Study.  
Cardiac Arrhythmia 
Upon inspection of ECG data, those with first, second, and third degree atrioventricular 
block, left bundle branch block, right bundle branch block, incomplete left bundle branch block, 
incomplete right bundle branch block, nonspecific intraventricular conduction delay, Wolff-
Parkinson-White syndrome (WPW), atrial fibrillation, atrial flutter, premature atrial contraction, 
premature ventricular contraction, left or right atrial hypertrophy were considered to have a 
CA(B.J. et al., 2016).  
Rhythm Abnormalities 
Of those participants within the CA group, those with left or right atrial hypertrophy, atrial 
fibrillation, atrial flutter, WPW, premature atrial contraction, or premature ventricular contraction 
were further sub-categorized to RA.  
Conduction Abnormalities  
Lastly, participants with first, second, and third-degree atrioventricular block, left bundle 
branch block, right bundle branch block, incomplete left bundle branch block, incomplete right 
bundle branch block, and nonspecific intraventricular conduction delay were subcategorized to 
conduction abnormality (CAb) (B.J. et al., 2016).  
Objective Sleep Variables (Polysomnography) 
All participants underwent a polysomnography study which included continuous EEG and 
ECG recording, as well as blood pressure, and oxygen saturation measurements. All sleep-related 
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data was then categorized into: i) sleep stage and progression variables; ii) quantity and quality of 
sleep measures, and; iii) measures of arterial blood oxygenation at various stages of sleep.  
 
Sleep Stages and progression 
In addition to total sleep time, we obtained the percentage of time each participant spent in 
each stage of sleep [% time in Rapid Eye movement sleep (REM), % Time in Stage 1 Non-Rapid 
Eye movement Stage (NREM-1), % Time in Stage 2 Non-Rapid Eye Movement (NREM-2), and 
% Time in Non Rapid Eye Movement stage 3 and 4 combined (NREM-3/4)].   
Quantity and Quality of Sleep Measures 
Total sleep time, obtained by polysomnography, represents the total number of minutes 
that participants were sleeping, whereas quality of sleep was assessed by four separate but related 
measures.  
Wake After Sleep Onset (WASO) 
Wake After Sleep Onset (WASO) is one of the most widely used measurements of sleep 
quantity. It measures the number of minutes that participants wake up post nocturnal cycle 
initiation. These wake episodes can be as pronounced as participants waking up to use the 
bathroom, or as minimal as a momentarily wake, which is typically not remembered by 
participants. This variable is represented as sum of all minutes spent awake after the participant 
falls asleep.  
Sleep Efficiency 
Similar to WASO, sleep efficiency computes the percentage of time that a person was 
asleep while in bed, and is obtained by dividing the number of minutes slept by total minutes in 
bed. This variable is expressed as a percentage of overall time spent in bed.  
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Sleep Latency 
By contrast, sleep latency represents the length of time (in minutes) it takes to transition 
from a state of wakefulness to the first and lightest stage of non-rapid eye movement (NREM-1) 
sleep. This latency variable is typically measured in minutes and demonstrates the ease of falling 
asleep.  
Sleep to awake shift (SWS) 
Sleep to awake shift (SWS) measures the number of times that a person wakes up after 
sleep initiation. Specifically, SWS is measured by number of times that a person experiences sleep 
rhythm disruption (i.e. NREM-1 sleep is disrupted). In contrast with WASO, which measures the 
total number of minutes that participants are awake after the first instance of sleep initiation, SWS, 
measures the number of times that a person was awoken after sleep initiation.  
Arterial Oxygen Saturation During Various Stages of Sleep  
Sleep apnea results in reduced oxygenation during sleep, which can present as rhythm and 
conduction abnormalities. Average and minimum blood oxygen saturation rate during REM and 
NREM sleep were therefore retained for further analysis. 
Subjective Sleep Variable 
The SHHS collected numerous questionnaire-based (subjective) sleep measure variables. 
For the purposes of this analysis, we focused on habits that can interfere with normal night sleep 
quality such as afternoon naps and the total number of naps per week, on the basis of the following: 
“During a usual week, how many times do you nap for 5 minutes or more?”. Response options 
included none or one or more. Afternoon naps were assessed by the question: “Do you try to "make 
time" in your schedule for a regular nap or "siesta" in the afternoon?”. Response options included 
the four following options: “Never”, “Sometimes”, “Often”, or “Always”, and was recoded to 
“Regular Afternoon Naps” (Sometimes/Often/Always vs Never) in the current analysis. 
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Sample Selection 
Inclusion Criteria 
All participants with complete and available history, ECG, Polysomnography, and 
demographics data were included in the study. 
Exclusion Criteria 
Participants with missing sleep data were excluded from the analysis. Additionally, in order 
to reduce bias in our sample, participants with existing cardiac pacemaker, or implantable 
cardioverter defibrillator (ICD) were excluded from the study analysis.  
Participant Screening and Outcome Assignment 
Overall, total 3,984 participants (Control: 3,469, CA: 515) were initially assessed and 
screened for eligibility. Participants within CA group were further divided to those with rhythm 
abnormalities (n=240), or conduction abnormalities (n=275). Overall, a total of 531 participants 
were excluded due to missing critical data points (NSR: 515, CA: 18 (RA:4, CAb: 12)). As such, 
the final sample size yielded 3,453 participants, of which 2,945 were in NSR and 499 others in CA 
group (RA:236, CAb: 263). A summary of the derivation of the final analytic sample is displayed 
in Figure 1.  
Statistical Analysis  
Baseline characteristics of study participants were described by mean and standard 
deviation for continuous measures, and with frequency and % for categorical variables.  Group-
based differences in baseline characteristics (arrhythmia, rhythm abnormalities, and conduction 
abnormalities) were compared to those in normorhythmic category using an independent t-test for 
continuous variables and chi-square for categorical variables. The relationship between established 
arrythmia risk factors and emerging sleep parameters were assessed in univariate logistic 
regression. Tertiles of each sleep parameter with arrhythmia and each arrhythmia subcategory was 
then assessed using unadjusted and age- and sex-adjusted logistic regression, with normorhythmic 
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participants as the referent. First-order interactions for age- and sex- with all sleep parameters was 
assessed, and because no effect modification was found, only overall pooled estimates were 
presented. All analyses were conducted in SPSS v23 with statistical significance set at an alpha of 
0.05.  
Ethics 
This secondary analysis was subsequently approved by the Human Participants Research 
Committee of York University. 
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RESULTS 
Study Population 
Sample Selection 
A total of 3,984 participants from the SHHS were assessed for eligibility. Cardiac 
Arrhythmia (CA) was present in 515 participants and absent from the remainder of the sample 
(Normorhythmic (NSR): 3,469). Of those with CA, 240 participants had rhythm abnormalities 
tachyarrhythmia (RA), and 275 suffered from conduction abnormalities (CAb). After excluding 
participants with missing sleep data (n=515 from the NSR, n=4 RA, and n=12 Cab) a final sample 
of 3,453 [2,954 in the NSR group and 499 in the CA group (RA: n=236, CAb: n=263)] was 
available for analysis (Figure 1).  
Demographic and Clinical Characteristics 
Within the complete sample, participants were 68.1± 10.6 years of age (Control: 67±10.5, 
CA: 74.4±9.2, NSR: 67±10.5), with higher mean ages among the RA and CAb subgroups  (NSR: 
67±10.5 vs RA: 74.6±9.3, P<0.0001, and NSR: 67±10.5 vs CAb: 74.1±9.1, P<0.0001). Overall, a 
small majority of participants were male (total: 54%; NSR: 55.8% vs CA: 56.3%, P=0.02) with a 
modestly higher percentage of male participants in the CA (vs NSR) groups (RA: 55.1%, and 
CAb,: 57.4% vs NSR: 55.8%, both p<0.0001). SHHS participants were also largely of white 
European ancestry and married, with no notable subgroup variation. By contrast, the prevalence 
of hypertension (HTN), and history of myocardial infarction (MI) and coronary artery bypass graft 
procedures (CABG) were higher in the CA group and its sub-groups compared to normorhythmic 
participants (HTN: NSR: 53% vs CA: 72.9%, P<0.0001, MI: NSR: 4.9% vs CA: 12.2%, P=0.003, 
CABG: NSR: 2.3% vs CA: 8.4%, P<0.0001); however, there were no differences in BMI or history 
of stroke. Complete demographics and comorbidity data are presented in Table1.  
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Sleep Quality Measures  
A total of five sleep quality measures and their relationship to cardiac arrhythmia were 
investigated in this study (Table 2). In general, individuals with CA had lower overall sleep time 
when compared to normorhythmic individuals (581.3±107.1 vs. 603.4±99.23 minutes, p<0.0001), 
a finding that persisted when compared within the RA and Cab subgroups (603.4±99.21 vs 
575.4±107 and 586.6±108 respectively, P<0.0001 in both cases). Furthermore, those with CA had 
more sleep-to-awake shifts, and total WASO minutes (30.4±16.6 vs. 27.9±13.1 times, P<0.0001, 
and 69.9±47.8 vs. 58±40.1 minutes, P<0.0001, respectively). Similarly, those with normal 
conduction anatomy had more efficient sleep compared to those with pathology (83.9%±9.5% vs. 
80.8%±11.1%, P<0.0001), despite no differences in sleep latency. These findings held true for 
participants in both the rhythm and conduction abnormality subgroups.  
Oxygenation at Various sleep stages 
In terms of sleep, normorhythmic participants had higher blood oxygen saturation at all 
sleep stages compared to those in CA group, an effect that was accounted for by lower average 
and minimum oxygen saturation during REM sleep in the CAb subgroup only (Average SaO2 
REM: CAb: 93.4%±6.6% vs NSR: 94.2%±5.5%, P<0.05, Minimum SaO2 REM: CAb: 
85.5%±8.3% vs. 86.9%±7.5%, P<0.05). Conversely, the difference in minimum and average blood 
oxygen saturation during NREM was lower only among those in the RA (but not CAb) subgroup 
(Average SaO2 NREM: RA: 91.2%±1.8% vs NSR: 94.6%±1.8%, P<0.05, Minimum SaO2 NREM: 
RA: 85.9%±6.9% vs. 87.5%±5%, P<0.05). Finally, while participants with CA and the RA and 
CAb subgroups spent more time in sleep apnea (CA: 4.8±8.8 vs. NSR: 2.7±6.1, P<0.05) and 
hypopnea, only differences for time in hypopnea persisted within the RA and CAb subgroups 
(Table 3). 
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Sleep Progression and Stages 
Beyond the findings presented above, polysomnography data allowed us to further examine 
the percent of time participants spend in each sleep stage. Here again, those in CA and its 
subgroups tended to have poorer sleep quality in that they spent less time in REM sleep compared 
to those who were normorhythmic (CA: 18.8±6.1 vs NSR: 20.4±6 minutes, P<0.0001). On the 
other hand, with the exception of the CAb group for Stage 3/4 sleep, no differences in time spent 
in non-REM sleep stage were observed for any other group. (Table 4).  
Napping Habits 
A number of other self-reported measures of sleep patterns provides new insight into the 
relationship with CA pathology. Specifically, taking a regular afternoon nap, defined as regular or 
everyday naps, were higher amongst those in CA patients and its subgroups (NSR:14.8%, vs CA: 
22.9%, and RA: 21.9%, and CAb: 23.7% respectively, P<0.0001). It is also noteworthy that most 
of the participants in NSR group did not nap during the week, while this was not true for the CA 
group, yielding a higher prevalence of individuals who took 1 or more naps per week in CA group 
compared to NSR (Table 5). 
 
 
Sleep Related Predictors of Cardiac Arrhythmia manifestation 
To test and determine the sleep-related predictors of CA, all continuous variables were 
divided into tertiles and categorized accordingly. The tertiles for each variable are found in tables 
5 through 9. 
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Sleep Quality Measures  
Sleep Time 
Unadjusted logistic regressions revealed that compared to 8 to 10 hour a night sleepers, 
those who slept between 6-8 hours (OR: 1.4, 95%CI: 1.1-1.2, p=0.02) and 6 or less hours (OR: 
2.6, 95%CI: 1.5-4.3, p<0.0001) had higher odds of arrhythmia. After adjustment for age and sex, 
those who slept less than 6 hours per night remained twice as likely to report a cardiac arrhythmias 
(ORadj: 2.1, 1.2-3.5, p=0.008; RA: ORadj: 2.2, 1.1-4.4, p=0.03, and; CAb: ORadj: 1.9, 1-3.9, 
p=0.05).  
WASO 
For wake-after-sleep onset, the findings were less consistent. Whereas the initial 
unadjusted models revealed that waking after more than 35 minutes of sleep onset was a significant 
predictor of cardiac arrhythmia, no significant effect was found for conduction abnormalities, and 
only WASO above 65 minutes was related to rhythm abnormalities. Nonetheless, once the models 
were adjusted for age and sex, WASO more than or equal to 65 remained a significant predictor 
of rhythm (ORadj:1.4, 95%CI:1.1-1.9, p=0.03), but not conduction abnormalities or CA overall 
(CA: ORadj:1.1, 95%CI: 0.85-1.4, p=0.14, CAb: ORadj:0.88, 95%CI: 0.63-1.2, p=0.29 ).  
Sleep Efficiency 
Finally, our preliminary analyses revealed that sleep efficiency less than or equal to 80.9% 
was a significant predictor of CA, RA, and CAb, a finding that persisted once adjusted for age and 
sex (CA: ORadj:1.95%CI: 1.1-2, p=0.01). Notwithstanding the above, sleep latency, and the 
number of sleep-to-wake shifts per night were not significant predictors of cardiac arrhythmia, 
rhythm or conduction abnormalities in the crude or adjusted models.  
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Oxygenation at Various sleep stages 
Minimum Arterial Blood Saturation 
In an effort to build upon the findings of the sleep stage analysis presented above, additional 
analyses were undertaken to examine whether minimum and average arterial blood saturation 
during REM and NREM sleep were significant predictors of CA. At the bivariate level, minimum 
oxygen saturation less than 89.9% and 86.9% were significant predictors of cardiac arrhythmia 
during REM and NREM sleep, respectively (Min SaO2 REM: OR:1.5, 95%CI: 1.2-1.9, p=0.001, 
and Min SaO2 NREM: OR:1.8, 95%CI: 1.4-2.3, P<0.0001), a finding that persisted within RA and 
CAb subgroups (Table 7). Once adjusted for age and sex, however, only minimum arterial blood 
oxygen saturation during REM sleep remained a significant predictor of CA (ORadj:1.4, 95%CI: 
1.1-1.7, p=0.02).  
Mean Arterial Blood Saturation 
Similar trends were observed for average arterial blood oxygen saturation. At the bivariate 
level, average SaO2 of 93.9% or less during NREM sleep, and 95.6% or less during REM sleep 
was related to CA (Average SaO2 REM: OR:1.5, 95%CI: 1.1-1.9, p=0.002, and Average SaO2 
NREM: OR:1.6, 95%CI: 1.3-2.0, P<0.0001), only a minimum oxygen saturation of 93.8% or less 
during REM sleep was a significant predictor of CA (ORadj:1.3, 95%CI: 1-1.7, p=0.05) and rhythm 
(ORadj:1.75, 95%CI: 1.3-2.4, p=0.001), but not conduction abnormalities, once adjusted for age 
and sex.    
Disturbances to Regular Blood Oxygenation 
To examine whether previous findings on sleep apnea and cardiac health extend to CA and 
its subtypes, we undertook a further analysis of disturbances to regular oxygenation. At the 
bivariate level, spending 1.5% or more of total sleep time in apnea was significantly related to CA, 
RA, and Cab; however, once adjusted for age and sex, only the relationship with rhythm 
abnormalities (ORadj:1.4, 95%CI: 1-1.9, p=0.04) remained. Similarly, while percent time spent in 
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hypopnea (19.4% or more) was related to CA and its subcategories, this effect was abolished after 
further adjustment.  
Sleep Stage Progression 
The final polysomnographic measure utilized in this study was the percent time spent in 
each stage of sleep. Findings from the crude analysis revealed that spending less than 22.5%, 6% 
and 61.7% in REM, NREM 1, and NREM 2, respectively, were associated with elevated odds of 
CA. Once adjusted for age and sex, spending less than 17.5% and 22.5% of overall sleep in REM 
predicted CA and conduction abnormalities respectively (CA: ORadj:1.1, 95%CI: 1-1.3, p=0.05, 
and CAb: ORadj:1.5, 95%CI: 1.1-2.2, p=0.01) (Table 4).  
Subjective Measures of sleep: Naps 
As with the descriptive findings discussed above, age- and sex-adjusted models revealed 
that everyday napping was associated with a 40-70% greater odds of CA and its subtypes (CA: 
ORadj:1.4, 95%CI: 1-1.8, p=0.05, RA: ORadj:1.5, 95%CI: 1-2.4, p=0.05 and CAb: ORadj:1.7, 
95%CI: 1.1-2.6 p=0.01), whereas less frequent napping (1 nap per week) was only associated 
with a greater likelihood of CA (ORadj:1.25, 95%CI: 1-1.6, p=0.05). 
DISCUSSIONS 
Main Findings 
In this study we sought to determine the relationship between sleep and cardiac arrhythmias 
through the use of polysomnography and ECG-derived heart rhythm data to characterize sleep 
across a host of objective (e.g. sleep quantity, quality, stage progression, and oxygenation) and 
subjective measures. In general, individuals with cardiac arrhythmias had lower sleep quality and 
quantity as illustrated by WASO, sleep time, sleep efficiency and number of sleep-to-awake shifts. 
This was also true for participants in the CA subcategories. Furthermore, REM sleep measures 
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were significantly different between normorhythmic and arrhythmia groups. After adjustment for 
age and sex, taking regular afternoons, sleep time less than or equal to 6 hours, as well as percent 
time spent in REM and oxygenation during REM sleep were significant predictors of CA. Finally, 
in all cases, subjective measures of sleep – most notably a napping frequency more than once a 
week or regular afternoon naps – were significant predictor of arrhythmias. 
Within subgroups of CA, rhythm, and conduction abnormalities, being in apnea for more 
than 1.5% of the overall sleep time and average blood oxygen saturation of less than or equal to 
93.8% during REM were significant predictors of rhythm abnormalities such atrial fibrillation and 
flutter. Additionally, sleep quality measures such as WASO more than 65 minutes, sleep efficiency 
less than 80.9%, and sleep time less than 6 hours were also significantly related to RA. Finally, 
sleeping for less than 6 hours a night and spending less than 22.5% of overall sleep in REM were 
also significantly related to conduction abnormalities, even after adjusting for age and sex. Thus, 
our outcomes demonstrate that while oxygenation during sleep is potentially a protector against 
arrhythmias, it is REM sleep that plays a major role in regulating heart rhythm. By the same token, 
the overall sleep quantity is an extremely important contributor to CA, RA, and CAb. This is while 
that quality of sleep measures such as wake after sleep onset, and sleep efficiency were only 
significant in predicting pathologies associated solely with rhythm abnormalities.  
Sleep Quantity and Deprivation  
Previous studies have provided detailed insight into the relationship between 
cardiovascular disease and sleep, most notably sleep quantity (Ayas et al., 2003; Cappuccio, 
D’Elia, Strazzullo, & Miller, 2010; Jackson et al., 2015; Knutson, 2010; Knutson, Spiegel, Penev, 
& Van Cauter, 2007; Knutson et al., 2009; Leung & Douglas Bradley, 2001; Luyster et al., 2012; 
Spiegel, Tasali, Leproult, & Van Cauter, 2009; Wolk et al., 2005), quality(Hoevenaar-Blom et al., 
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2011), oxygenation, and potential apneas(Depner et al., 2014). Consistent with previous literature 
on cardiometabolic health (e.g. higher BMI, type 2 diabetes, hypertension(Knutson, 2010), 
coronary artery disease(Ayas et al., 2003), and heart attack and stroke(Knutson, 2010; Knutson et 
al., 2007, 2009; Spiegel et al., 2009)), we found that sleeping less than 6 hours a night was a 
significant predictor of rhythm and conduction abnormalities. Similarly, in a study by Genuardi et 
al. each hour reduction in sleep resulted in 17% increased risk of developing atrial fibrillation 
(Genuardi et al., 2019). These findings are consistent with the results of our study; however, we 
found that sleep duration of 6 hours or less was associated with a 2.2-fold greater likelihood of 
having a rhythm abnormality.  Therefore, it is important to maintain a healthy sleep habits in order 
to reduce the risk of developing arrhythmias as well as other metabolic disorders(Irwin et al., 
2016). The MORGEN study clearly demonstrated that with lower sleep duration and quality have 
a much higher risk of CVD and CHD specifically(Hoevenaar-Blom et al., 2011), however, this 
study did not investigate cardiac electrical abnormalities, and thus, we add to this literature with 
our finding that decline in sleep measures especially during REM is associated with CA 
manifestation regardless of age and sex.  
Wake after sleep onset (WASO) and Sleep Efficiency 
Quality of sleep is as an important indicator of proper nocturnal cycle progression 
(Hoevenaar-Blom et al., 2011). In a systematic review by Aziz et al. (2017), reductions in the 
quality and quantity of sleep were strongly associated with clinical and subclinical cardiovascular 
disease(Aziz et al., 2017). The health consequences of two measures of sleep quality – namely 
sleep efficiency and WASO  –  have been examined at length(Quan et al., 1997). For example, in 
a cross-sectional study of 270 female shift workers, half of whom were hospital shift workers while 
the other half had regular 8-hour a day jobs, found that shift workers had significantly lower sleep 
 28 
quality as well as higher incidences of CVD(Lajoie, Aronson, Day, & Tranmer, 2015). While these 
findings are in general consistent with our study, we also found that sleep quality measures such 
as WASO and sleep efficiency were strong predictors of rhythm abnormalities.  
 
Rapid Eye Movement Sleep and Oxygenation 
While separate, the findings that sleep efficiency and WASO are related to CA are 
consistent with our finding of a major role of REM sleep in arrhythmias, as REM sleep is thought 
to be integral for cardiovascular relaxation and longer-term cardiac health(Koo, Patel, Strohl, & 
Hoffstein, 2008a; Leung & Douglas Bradley, 2001),(Choi, Park, Yu, Ryu, & Ha, 2016). Indeed, 
using the SHHS dataset, Aurora et al. have previously reported a relationship between apnea and 
lack of oxygenation during REM sleep with CVD endpoints (Nisha Aurora et al., 2018). 
Furthermore, Aurora et al. (Nisha Aurora et al., 2018) utilized the apnea-hypopnea index (AHI) to 
classify the oxygenation during REM and found that those with high AHI had a significantly higher 
prevalence of cardiovascular disease(Nisha Aurora et al., 2018). These findings are consistent with 
the results of our study which demonstrated that reduced arterial blood oxygenation during REM 
was associated with a 30% greater likelihood of arrhythmias. Unsurprisingly, there is typically a 
higher chance of apnea and hypopnea during REM sleep compared to the other stages(Grace, 
Hughes, & Horner, 2013), as it is during this stage that muscles are relaxed and paralyzed. The 
neurotransmitters involved in REM-mediated paralysis can therefore cause paralysis of the 
epiglottis, which in turn contribute to a blocking of the larynx and a subsequent reduction in, or 
complete blockage, of oxygen transmission(Grace et al., 2013). This is also supported by a study 
by Choi et al. wherein individuals with sleep apnea were found to have more severe reductions in 
oxygenation during REM sleep compared to the other stages(Choi et al., 2016). Moreover, because 
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the amount of time one spends in REM sleep is independently related to cardiometabolic 
health(Calandra-Buonaura, Provini, Guaraldi, Plazzi, & Cortelli, 2016), disruption in the quality 
of sleep in this stage supports a role for pathology in the autonomic regulation pathway(Calandra-
Buonaura et al., 2016).  One further explanation for the importance of REM sleep to arrhythmia 
development is that  some, but not all, homeostasis processes are suspended(Ephron & Carrington, 
1966). Of note, there is a large fluctuation in heart rate, breathing, and blood pressure that does not 
occur in any of the other stages of sleep or even wakefulness(Ephron & Carrington, 1966).  
 
 
 
Sleep Apnea and Arrhythmia 
A considerable body of research now supports a relationship between sleep apnea and atrial 
fibrillation(Ravi et al., 2003; S. et al., 2004), and several of these studies can be drawn upon to 
provide context to findings from the current investigation. In an earlier analysis of the SHHS by 
Tung et al. central sleep apnea was found to be associated with a higher prevalence of AF(Tung et 
al., 2017). In the present analysis, being in apnea for 1.5% or more of overall sleep time was 
associated with a higher prevalence of rhythm abnormalities, to the extent that apnea during sleep 
was associated with a 1.42 greater odds of rhythm abnormalities as compared to those with no 
sleep apnea. This finding is further supported by an analysis of 8,256 participants by Kendzersak 
et al. which found that having 30 AHI events per hour (Kendzerska, Gershon, Atzema, Hawker, 
& Leung, 2017) and spending more than 10 minutes of sleep with arterial blood saturation below 
90 percent increases the risk of AF hospitalization by 92% and 281%, respectively. This means 
the minimum blood oxygen saturation below 90 percent can nearly triple the likelihood of 
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hospitalization for atrial fibrillation, which is consistent with the findings of the current 
study(Kendzerska et al., 2017). However, unlike the current study, Kendzersak et al. (REF) did 
not investigate deoxygenation in each particular stage of sleep. As a result, the current study 
provides much needed insight into the relative importance of apnea and desaturation in the various 
sleep stages 
 
Afternoon Naps and Prevalence of Arrhythmia 
Accumulating evidence now suggests that regular daytime napping may contribute to a  
higher risk of CVD, and increased morbidity and mortality amongst older adults(Ancoli-Israel & 
Martin, 2006). Within our sample of middle-aged adults, our study demonstrated that regular naps 
were associated with a 70% greater likelihood of CAb, and a 50% greater likelihood of rhythm 
abnormalities. There are a number of possible explanations for the aforementioned findings, 
including sleep fragmentation, pre-existing disease, and overall poorer sleep quality (Ancoli-Israel 
& Martin, 2006; Carskadon, Brown, & Dement, 1982; Goldman et al., 2008). In a cross-sectional 
study of 235 middle aged adults, Goldman et al. found that those with regular naps during the day 
had higher fragmented and lower quality sleep overall(Goldman et al., 2008), as fragmentation  is 
known to reduce nocturnal sleep efficiency and quality(Carskadon et al., 1982).  It stands to reason 
that this is one of the explanations for why we observe a higher likelihood of arrhythmia in those 
with regular daily naps, and is consistent with emerging literature that lower quantity and quality 
of sleep is associated with a higher likelihood of arrhythmia(Cappuccio et al., 2010; Hoevenaar-
Blom et al., 2011; Knutson et al., 2007; Leung & Douglas Bradley, 2001; Parthasarathy et al., 
2015). As such, factors that contribute to a reduction in these sleep parameters may contribute to 
the development of arrhythmia and represent a suitable target for intervention. (Ancoli-Israel & 
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Martin, 2006). More research is however necessary, as these findings are in contrast to earlier 
studies that recommended regular afternoon naps for improved daily function and overall 
health(Dinges, 1992). 
Strengths and Limitations 
This study was done using data obtained by the SHHS. As such, the cross-sectional nature 
of the analysis, and lack of a matched control design prevents casual inference. Furthermore, some 
pre-existing conditions, as well as self-reported measures of napping may have introduced 
response bias in the outcomes. On the other hand, this study had a large sample with objectively 
assessed measures of sleep, which ensures a high level of internal and external validity.   
 
CONCLUSION 
Cardiac arrhythmias, comprising of rhythm and conduction abnormalities, are one of the major 
causes of morbidity and mortality in adults. Analyzing self-report, electrocardiogram, and 
polysomnography data from over two thousand SHHS participants we found that oxygenation and 
sleep stage progression - particularly the amount of time one spends in REM, apnea, and minimum 
arterial blood oxygenation during different stages - are important predictors of arrhythmia. 
Prospective studies are needed to further investigate the effects of sleep habits on cardiac 
arrhythmias; however, findings from this study serve as a starting point for future work to examine 
the sleep related behaviors with arrhythmias, work that may ultimately provide a more 
comprehensive understanding of primary and secondary prevention of these conditions.  
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